RitaS.AxelrodMD

Oncology • Philadelphia, PA

Professor Medical Oncology Thomas Jefferson University; Director, Jefferson Oncology Group

Join to view full profile

Dr. Axelrod is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Axelrod's full profile

Already have an account?

Office
925 Chestnut St
Ste 220
Philadelphia, PA 19107
Phone+1 215-955-8874

Fax+1 215-503-2715
Is this information wrong?

Education & Training

Main Line Health System/Lankenau Medical CenterFellowship, Hematology and Medical Oncology, 1975 - 1976
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1974 - 1975
Medical College of GeorgiaResidency, Internal Medicine, 1972 - 1973
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1970 - 1971
New York University School of MedicineClass of 1970

Certifications & Licensure

DE State Medical License 2017 - 2025
NJ State Medical License 1985 - 2025
PA State Medical License 1974 - 2024
NY State Medical License 1971 - 2014
GA State Medical License 1972 - 1995
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
America's Top Doctors Castle Connolly, 2009-2014
Philadelphia Magazine Castle Connolly, 2005-2014
America's Top Doctors for Cancer Castle Connolly, 2008-2013
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor Start of enrollment: 2007 Dec 01
Active, not recruiting
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation Start of enrollment: 2004 Oct 01
Completed
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2009 Nov 01
Active, not recruiting
Phase 3
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy Start of enrollment: 2013 Nov 11
Completed
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jul 22
Completed
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer Start of enrollment: 2019 May 17
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.
Ramez Philips, Dev Amin, Jena Patel, Michael C Topf, Jennifer M Johnson, Voichita BarAd, Rita Axelrod, Athanassios Argiris, Christopher Fundakowski, Adam J Luginbuhl, ...> ;Cancer. 2024 Mar 15
1 citations
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.
Jennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, Ayesha Ali, Voichita Bar Ad, Rita Axelrod, Emily Lorber, Joseph Curry, David M Cognetti, Adam J Luginbuhl, M...> ;Journal for Immunotherapy of Cancer. 2023 Aug 1
10 citations
Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1.
Martin Reck, Tudor-Eliade Ciuleanu, Jong-Seok Lee, Michael Schenker, Bogdan Zurawski, Sang-We Kim, Mauricio Mahave, Aurelia Alexandru, Solange Peters, Adam Pluzanski, ...> ;Journal of Thoracic Oncology. 2023 Aug 1
1 citations
In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the...
Ayesha S Ali, Gregor Manukian, Jennifer M Johnson, Ioannis Vathiotis, Rita Axelrod, Scott W Keith, Joseph Curry, David Cognetti, Adam Luginbuhl, Athanassios Argiris, V...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Sep 1
4 citations
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck ...
Jimmy J Caudell, Pedro A Torres-Saavedra, David I Rosenthal, Rita S Axelrod, Phuc Felix Nguyen-Tan, Eric J Sherman, Randal S Weber, James M Galvin, Adel K El-Naggar, A...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Jul 1
17 citations
Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma.
Adam J Luginbuhl, Jennifer M Johnson, Larry A Harshyne, Alban J Linnenbach, Sanket K Shukla, Angela Alnemri, Gaurav Kumar, David M Cognetti, Joseph M Curry, Nikita Kot...> ;Clinical Cancer Research. 2022 Mar 1
23 citations
Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment...
Dante J. Merlino, Jennifer Johnson, Madalina Tuluc, Stacey M. Gargano, Robert Stapp, Larry Harshyne, Benjamin E. Leiby, Adam E. Flanders, Ralph Zinner, Rita Axelrod, J...> ;Frontiers in Oncology. 2020 Dec 2
Not All Head and Neck Squamous Cell Carcinomas Are Created Equal: Some Are More Aggressive.
Lillian C. Man, Rita Axelrod> ;International Journal of Radiation Oncology, Biology, Physics. 2017 Dec 1
28 citations
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With ...
Minh Tam Truong, Qiang Zhang, David I. Rosenthal, M. A. List, Rita Axelrod, Eric J. Sherman, Randal S. Weber, Phuc Felix Nguyen-Tân, Adel K. El-Naggar, Andre Konski, J...> ;International Journal of Radiation Oncology, Biology, Physics. 2017 Mar 15
48 citations
The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Joanne B. Weidhaas, Jonathan Harris, Dörthe Schaue, Allen M. Chen, Robert Chin, Rita Axelrod, Adel K. El-Naggar, Anurag K. Singh, Thomas J. Galloway, David Raben, Dian...> ;JAMA Oncology. 2017 Apr 1
27 citations
Neutrophil to lymphocyte ratio associated with prognosis of lung cancer.
Voichita Bar-Ad, Joshua D. Palmer, Ling Li, Yinzhi Lai, Bo Lu, Ronald E. Myers, Zhong Ye, Rita Axelrod, Jennifer Johnson, Maria Werner-Wasik, Scott W. Cowan, Nathaniel...> ;Clinical & Translational Oncology. 2017 Jun 1
18 citations
PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic s...
Lori J. Wirth, Shaker Dakhil, Gabriela Kornek, Rita Axelrod, Douglas Adkins, Shubham Pant, Paul H. O'Brien, Philip R. Debruyne, Kelly S. Oliner, Jun Dong, Swami Muruga...> ;Oral Oncology. 2016 Oct 1
26 citations
Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience
Voichita Bar-Ad, Q. Zhang, Paul M. Harari, Rita Axelrod, David I. Rosenthal, Andy Trotti, Christopher U. Jones, Adam S. Garden, Guobin Song, Robert L. Foote, David Rab...> ;International Journal of Radiation Oncology, Biology, Physics. 2016 Aug 1
11 citations
Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head a...
Peter H. Ahn, Mitchell Machtay, Pramila R. Anne, David Cognetti, William M. Keane, Evan Wuthrick, Adam P. Dicker, Rita Axelrod> ;American Journal of Clinical Oncology. 2016 Jul 7
Reply to D. Adkins et al
Rita Axelrod, Eric J. Sherman, Adam S. Garden, Phuc Felix Nguyen-Tan, Andy Trotti, Sue S. Yom, Qiang Zhang> ;Journal of Clinical Oncology. 2015 Feb 23
41 citations
Randomized Phase II Study of Carboplatin and Paclitaxel With Either Linifanib or Placebo for Advanced Nonsquamous Non–Small-Cell Lung Cancer
Suresh S. Ramalingam, Mikhail Shtivelband, Ross A. Soo, Carlos H. Barrios, A. Makhson, J.G.M. Segalla, K. Pittman, Petr Kolman, José Rodrigues Pereira, Gordan Srkalovi...> ;Journal of Clinical Oncology. 2015 Feb 10
11 citations
Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests
Kejin Zhang, Yinzhi Lai, Rita Axelrod, Barbara G. Campling, Terry Hyslop, Jesse Civan, Charalambos C. Solomides, Ronald E. Myers, Bo Lu, Voichita Bar Ad, Bingshan Li, ...> ;International Journal of Cancer. 2015 Jan 15
33 citations
Current Management of Locally Advanced Head and Neck Cancer: The Combination of Chemotherapy With Locoregional Treatments
Voichita Bar-Ad, Joshua D. Palmer, Hushan Yang, David Cognetti, Joseph Curry, Adam Luginbuhl, Madalina Tuluc, Barbara G. Campling, Rita Axelrod> ;Seminars in Oncology. 2014 Dec 1
19 citations
A Pilot Study of Hypofractionated Stereotactic Radiation Therapy and Sunitinib in Previously Irradiated Patients With Recurrent High-Grade Glioma
Evan Wuthrick, Walter J. Curran, Kevin Camphausen, Alexander Lin, Jon Glass, James J. Evans, David W. Andrews, Rita Axelrod, Wenyin Shi, Maria Werner-Wasik, E. Mark Ha...> ;International Journal of Radiation Oncology, Biology, Physics. 2014 Oct 1
16 citations
Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemot...
Voichita Bar-Ad, Benjamin E. Leiby, Matthew E. Witek, Ying Xiao, Yunfeng Cui, Yang Dai, J Cao, Rita Axelrod, Barbara G. Campling, Stefan Both, Maria Werner-Wasik> ;American Journal of Clinical Oncology. 2014 Oct 1
145 citations
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.
K Kian Ang, Qiang Zhang, David I Rosenthal, Phuc Felix Nguyen-Tan, Eric J Sherman, Randal S Weber, James M Galvin, James A Bonner, Jonathan Harris, Adel K El-Naggar, M...> ;Journal of Clinical Oncology. 2014 Sep 20
3 citations
E5501: phase II study of topotecan sequenced with etoposide/ cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive‑stage small‑cell lung cancer
Taofeek K. Owonikoko, Joseph Aisner, Xin Victoria Wang, Suzanne E. Dahlberg, Eric H. Rubin, Suresh S. Ramalingam, Murugesan Gounder, Paul Gregory Rausch, Rita Axelrod,...> ;Cancer Chemotherapy and Pharmacology. 2014 Jan 1
8 citations
Sarcoidosis mimicking metastatic bone disease in head and neck cancer.
Cecilia Arana Yi, Peter McCue, Marc Rosen, Mitchell Machtay, Rita Axelrod, Gloria J. Morris> ;Seminars in Oncology. 2013 Oct 1
5 citations
Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab
Nicholas G. Zaorsky, Yunguang Sun, Zi-Xuan Wang, Joshua D. Palmer, Paolo Fortina, Charalambos C. Solomides, Maria Werner-Wasik, Adam P. Dicker, Rita Axelrod, Barbara G...> ;Cancer Biology & Therapy. 2013 Aug 2
22 citations
The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy ...
Yaacov Richard Lawrence, Rebecca Paulus, Corey J. Langer, Maria Werner-Wasik, Mark K. Buyyounouski, Ritsuko Komaki, Mitchell Machtay, Colum Smith, Rita Axelrod, Todd H...> ;Lung Cancer. 2013 Jun 1
Join now to see all